These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8564763)

  • 1. Botulinum toxin therapy for blepharospasm in the otolaryngology clinic.
    Lassen LF; Adams J
    ORL Head Neck Nurs; 1994; 12(3):12-3. PubMed ID: 8564763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Injection of botulinum toxin type B for the treatment of otolaryngology patients with secondary treatment failure of botulinum toxin type A.
    Guntinas-Lichius O
    Laryngoscope; 2003 Apr; 113(4):743-5. PubMed ID: 12671439
    [No Abstract]   [Full Text] [Related]  

  • 3. [A survey about the accessibility to botulinum toxin therapy for dystonia].
    Mezaki T; Hayashi A; Nakase H; Hasegawa K
    No To Shinkei; 2006 Mar; 58(3):219-24. PubMed ID: 16629446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Blepharospasm: treatment with botulinum toxin].
    Barbosa ER; Silva HC; Haddad MS; Bittar MS
    Rev Hosp Clin Fac Med Sao Paulo; 1996; 51(6):220-3. PubMed ID: 9239894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Botulinum toxin therapy: from dreaded biological toxin to standard pharmaceutical].
    Schnider P; Voller B; Moraru K; Auff E
    Wien Klin Wochenschr; 1999 Oct; 111(20):825-9. PubMed ID: 10586486
    [No Abstract]   [Full Text] [Related]  

  • 6. Botulinum toxin in blepharospasm and oromandibular dystonia: comparing different botulinum toxin preparations.
    Bhidayasiri R; Cardoso F; Truong DD
    Eur J Neurol; 2006 Feb; 13 Suppl 1():21-9. PubMed ID: 16417594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin treatment for blepharospasm associated with myasthenia gravis.
    Hara K; Matsuda A; Kitsukawa Y; Tanaka K; Nishizawa M; Tagawa A
    Mov Disord; 2007 Jul; 22(9):1363-4. PubMed ID: 17486596
    [No Abstract]   [Full Text] [Related]  

  • 8. Botulinum toxin in movement disorders.
    Papapetropoulos S; Singer C
    Semin Neurol; 2007 Apr; 27(2):183-94. PubMed ID: 17390263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum toxin increases tearing in patients with Sjögren's syndrome: a preliminary report.
    Spiera H; Asbell PA; Simpson DM
    J Rheumatol; 1997 Sep; 24(9):1842-3. PubMed ID: 9292815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical symptoms, diagnosis and treatment of focal dystonias].
    Klivényi P; Vécsei L
    Orv Hetil; 2001 Oct; 142(42):2293-7. PubMed ID: 11760645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of botulinum toxin in ophthalmology: current concepts and problems].
    Tapiero B; Robert PY; Adenis JP; Riss I
    J Fr Ophtalmol; 1997; 20(2):134-45. PubMed ID: 9099272
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical and psychological factors influencing the efficacy of botulinum toxin in the treatment of hemifacial spasm and blepharospasm].
    Burbaud P; Arnaud A; Burbaud A; Lagueny A
    J Fr Ophtalmol; 1995; 18(12):751-7. PubMed ID: 8745707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The pharmacology of botulinum toxin].
    Bigalke H
    Med Monatsschr Pharm; 2002 Sep; 25(9):305-8. PubMed ID: 12369431
    [No Abstract]   [Full Text] [Related]  

  • 14. Therapeutic uses of botulinum toxin.
    Wheeler AH
    Am Fam Physician; 1997 Feb; 55(2):541-5, 548. PubMed ID: 9054223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bilateral vocal fold paralysis: an unusual treatment with botulinum toxin.
    Andrade Filho PA; Rosen CA
    J Voice; 2004 Jun; 18(2):254-5. PubMed ID: 15193660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum toxin in the treatment of blepharospasm and hemifacial spasm.
    Kenney C; Jankovic J
    J Neural Transm (Vienna); 2008; 115(4):585-91. PubMed ID: 17558461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical efficacy and tolerability of Xeomin in the treatment of blepharospasm.
    Jankovic J
    Eur J Neurol; 2009 Dec; 16 Suppl 2():14-8. PubMed ID: 20002742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complete secondary botulinum toxin therapy failure in blepharospasm.
    Dressler D
    J Neurol; 2000 Oct; 247(10):809-10. PubMed ID: 11127541
    [No Abstract]   [Full Text] [Related]  

  • 19. Dystonic frowning without blepharospasm.
    Hirota N; Hirota M; Mezaki T
    Parkinsonism Relat Disord; 2008 Nov; 14(7):579-80. PubMed ID: 18316230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum toxin for people with dystonia treated by an outreach nurse practitioner: a comparative study between a home and a clinic treatment service.
    Whitaker J; Butler A; Semlyen JK; Barnes MP
    Arch Phys Med Rehabil; 2001 Apr; 82(4):480-4. PubMed ID: 11295008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.